Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
Analysts expect modest revenue growth but pressure on profitability in the March quarter
PMDA is regarded among the most stringent regulatory bodies globally
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The company allocated €56 million to research and development for next-generation line solutions
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Subscribe To Our Newsletter & Stay Updated
